Evidence map›Paper›PMID 36051875›Full record

ReviewComputational and structural biotechnology journal2022

On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach.

Sangsoo Lim, Sangseon Lee, Yinhua Piao, MinGyu Choi, Dongmin Bang, Jeonghyeon Gu, Sun Kim

Abstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Artificial intelligence-assisted lead optimization in drug discovery: bridging computational advances and translational challenges.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sangsoo LimBioinformatics Institute, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.
Sangseon LeeInstitute of Computer Technology, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.
Yinhua PiaoDepartment of Computer Science and Engineering, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.
MinGyu ChoiDepartment of Chemistry, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.
Dongmin BangInterdisciplinary Program in Bioinformatics, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.
Jeonghyeon GuInterdisciplinary Program in Artificial Intelligence, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.
Sun KimDepartment of Computer Science and Engineering, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large number of chemical compounds are available in databases such as PubChem and ZINC. However, currently known compounds, though large, represent only a fraction of possible compounds, which is known as chemical space. Many of these compounds in the databases are annotated with properties and assay data that can be used for drug discovery efforts. For this goal, a number of machine learning algorithms have been developed and recent deep learning technologies can be effectively used to navigate chemical space, especially for unknown chemical compounds, in terms of drug-related tasks. In this article, we survey how deep learning technologies can model and utilize chemical compound information in a task-oriented way by exploiting annotated properties and assay data in the chemical compounds databases. We first compile what kind of tasks are trying to be accomplished by machine learning methods. Then, we survey deep learning technologies to show their modeling power and current applications for accomplishing drug related tasks. Next, we survey deep learning techniques to address the insufficiency issue of annotated data for more effective navigation of chemical space. Chemical compound information alone may not be powerful enough for drug related tasks, thus we survey what kind of information, such as assay and gene expression data, can be used to improve the prediction power of deep learning models. Finally, we conclude this survey with four important newly developed technologies that are yet to be fully incorporated into computational analysis of chemical information.

Indexed as

Chemical information modelingChemical spaceComputer-aided drug discoveryData augmentationDeep learning

Identifiers

PMID36051875
PMCPMC9399946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.